Brian Robb Douglass serves as CHIEF PRODUCT OFFICER at REPLIGEN CORP, where they oversee executive responsibilities. Since joining the company, Brian Robb Douglass has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 31, 2025 involved receiving (via award) 2,143 shares valued at $0.
Brian Robb Douglass currently holds 2,143 shares of REPLIGEN CORP (RGEN), valued at approximately $0. This represents their equity stake as CHIEF PRODUCT OFFICER.
Based on SEC Form 4 filings, Brian Robb Douglass has been a net neutral trader of RGEN stock. They have purchased $0 and sold $0 worth of shares.
Brian Robb Douglass's most recent insider trade was on Dec 31, 2025, when they sold 2,143 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |